CRISPR QC's technology enables scientists to increase editing efficiency and define a strategy to ac
Location: United States, California, San Diego
Employees: 11-50
Total raised: $11.6M
Founded date: 2021
Investors 3
| Date | Name | Website |
| - | BioTools I... | biotoolsin... |
| 08.01.2024 | Xcellerant... | xcellerant... |
| 08.11.2025 | Biobrit | biobrit.co... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 05.01.2024 | Series A | $10M | Xcellerant... |
| 11.01.2023 | Seed | $1.6M | - |
Persons 1
| Date | First Name | Last Name | Title | |||
| - | Ross | Bundy | President | linkedin.c... | - | r****y@cri... |
Mentions in press and media 8
| Date | Title | Description |
| 05.01.2024 | CRISPR QC secures $10M Series A investment from Xcellerant Ventures to assist in the continuous gfr | - |
| 11.01.2023 | CRISPR QC Closes $1.6M Seed Funding Round | CRISPR QC, a San Diego, CA-based provider of a gene editing analytics Platform, raised $1.6M in Seed funding. The round was led by Serra Ventures. The company intends to use the funds to advance commercial development of the platform and to... |
| 11.01.2023 | CRISPR QC Closes Seed Round at $1.6M | SAN DIEGO, CA, CRISPR QC has announced that they have closed their Seed Round at $1.6M. >> Click here for more funding data on CRISPR QC >> To export CRISPR QC funding data to PDF and Excel, click here CRISPR QC has annou... |
| 11.01.2023 | CRISPR QC acquires $1.6M of Seed funding to advance data analytics capabilities and commercial development | - |
| 10.01.2023 | CRISPR Gets $1.6M | San Diego-based CRISPR QC, a startup developing data and analytics tools for the gene editing market, announced on Tuesday afternoon that it has raised $1.6M in a seed funding round. The funding was led by Serra Ventures, and also included ... |
| - | CRISPRQC | “San Diego-based biotech. We empower scientists with unique insight into the CRISPR-Cas9 editing process, enabling them to engineer better edits.” |
| - | CRISPRQC | “Home | CRISPR QC” |
| - | CRISPR QC: Genetic Medicine Company Closes $10 Million In Funding | CRISPR QC, a San Diego-based biotechnology company that has developed the world’s first platform to precisely analyze the quality of the CRISPR/CAS9 gene editing system – has raised $10 million in funding led by Xcellerant Ventures. By offe... |